TAM-derived TGFβ can promote activation of cancer-associated fibroblasts and together, through ECM remodeling and increased ECM deposition, they can promote exclusion of CD8+ cytotoxic T cells from the tumor, facilitating immune evasion. The gene discussed is CD8A; the disease is cancer.